ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt
ABVC BioPharma, Inc. (ECOC) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt of $498 as of 2023-12-31, per its 10-K filed 2024-03-13.
Financial Statements › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt · last filed 2025-04-15
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $498.00.
- 2023-12-15: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $498.00.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt |
|---|---|
| 2023-12-31 | $498.00 10-K · filed 2024-03-13 |
| 2023-12-15 | $498.00 10-K · filed 2025-04-15 |